Multicenter observational study of real-world efficacy and safety of antithrombotic therapy underwent percutaneous coronary intervention (PCI)

Multicenter observational study of real-world efficacy and safety of antithrombotic therapy underwent percutaneous coronary intervention (PCI) - Multicenter observational study of efficacy and safety of antithrombotic therapy underwent percutaneous coronary intervention (PCI)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041849

Enrollment

1500

Registered

2020-10-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients those who have obtained the informed consent of the research subject

Exclusion criteria

Exclusion criteria: Patients with contraindications to antithrombotic therapy, Pregnant women, lactating women, women who may be pregnant

Design outcomes

Primary

Measure	Time frame
Major adverse cardiac or cerebrovascuar events: all cause death, non-fatal myocardial infarct, stent thrombosis, revascularization, stroke	—

Secondary

Measure	Time frame
Major and minor bleeding event	—

Countries

Japan

Contacts

Public ContactRiku Arai

Nihon University School of Medicine Division of Cardiology, Department of Internal Medicine

arai.riku@nihon-u.ac.jp03-3972-8111

Outcome results